M&M Behavioral Health

specializing in addiction recovery

CALL TODAY

1406 South Crain Highway, Ste 104 Glen Burnie, MD 21061

410.766.6624

MMBHS.COM

M & M Behavioral Health Solutions, LLC’s mission is to provide our clients with personalized, high-quality care. We work with children, teens, adults, and families to encourage personal growth and promote harmony in their everyday lives. Whether struggling with depression, anxiety, family relational problems, ADHD, trauma, substance abuse or any other difficulty, our staff is ready to assist you in creating personal growth, harmony, and balance in your everyday life. We are a full-service family practice of dedicated, experienced counselors who believe in working with our clients to maintain and improve their behavioral health. We work together to serve your entire family for all of your needs in all stages of life. Each counselor is licensed by the state of Maryland and comes to our practice with years of experience in various areas of specialties. Our board-certified nurse practitioners and psychiatrists work with each client in order to provide informed, consistent care at all times.

Our diverse, experienced

workforce includes licensed counselors, social workers, nurse practitioners, a psychiatrist and several addiction counselors.

MMBHS.COM

INDIVIDUAL COUNSELING GROUP COUNSELING MARITAL COUNSELING

We offer counseling, support, and guidance to individuals that are having trouble coping mentally or emotionally.

Mental

Health Our diverse, experienced workforce includes licensed counselors, social workers, nurse practitioners, a psychiatrist and several addiction counselors. We provide quality, client-centered services to our clients through clinically competent and culturally sensitive behavioral health and addictions services in the least restrictive environment possible.

M

ental health includes our emotional, psychological, and social well-being. It affects how we think, feel and act as we cope with life. It also helps

"M&M Behavioral Health Solutions, LLC hasbeen instrumental in helpingour familythrough adifficulttime ofloss.They alwaystreated ourfamilywith thehighest levelofcare and compassion." -Beth Crofton,MD

determine how we handle stress, relate to others, and make choices. Mental illnesses are serious disorders which can affect your thinking, mood, and behavior. There are many causes of mental disorders, for example, your genes or family history. Your life experiences, such as stress or a history of abuse, may also matter. Biological factors can also be part of the cause. Mental disorders are common, but treatments are available. The Counselors at M&M Behavioral Health Solutions are highly-skilled professionals who provide flexible, client-oriented therapy. We offer counseling, support, and guidance to individuals that are having trouble coping.

mentally or emot Some of Our Specialty Areas: Depression • Bipolar Disorder • Generalized Anxiety Disorder • Panic Disorder • Phobias • Eating Disorders • Obsessive Compulsive Disorder • Addiction • Substance Abuse • Suicidal Impulses • Self-Esteem • Marital Distress • Grief • Teen Issues • Parenting Skills

the largest treatment directory in the nation

Your Source forNews and Informationon Addiction, Recovery, andEverything In-Between.

Stay beautiful

Don’t do drugs

www.mmbhs.com 410.766.6624

Substance Abuse SERVICES

M&M Behavioral Health Solutions offers an outpatient substance abuse program that includes two levels of treatment - individual sessions and an Intensive Outpatient Program. Through either program, clients can expect a supportive, judge-free environment conducive to the recovery process. Both programs address a number of addictions: alcohol, drugs, gambling, video-gaming, and internet addiction. Individual Outpatient Services Our individual outpatient sessions aim to provide a more personalized approach to recovery. In these sessions a certified counselor addresses the body, mind, spirit, and emotions through a variety of techniques to help patients identify barriers to recovery. Intensive Outpatient Program Our substance abuse IOP program offers a flexible schedule and is currently accepting new members. To inquire about joining call the office and speak to a Client Care Coordinator. Many different areas and topics are covered in the IOP. Everyone is introduced to the following areas while in the IOP at M&M Behavioral Health Solutions: •Relapse Prevention Skills •How to Manage Urges and Cravings •Understanding the Brain Chemistry of Addiction •Progression of the Disease of Addiction • Introduction To the Twelve Steps •Spirituality •Stages of Change •Focus On Co-Occurring Disorders and the Effects On Addiction and Recovery •Effects of Addiction on Family ties Depending on your needs, you may be referred to additional comprehensive mental health treatment, or training in how to increase healthy life skills, or employment counseling.

1406 South Crain Highway, Ste 104, Glen Burnie, MD 21061 410.766.6624

M&M Behavioral Health Solutions provides an array of outpatient mental health and substance abuse treatment and counseling programs to serve our clients.

MMBHS.COM

Patients who wind up in emergency rooms because of drug use have far more types of drugs in their systems than the standard screening test used by hospitals is catching, a new study has found.

While the drug epidemic has focused on opioid use, two-thirds of patients who ended up at two University of Maryland Medical System emergency rooms in 2016 had multiple drugs in their systems — up to six were found in some urine samples. Emergency rooms tend to use a basic urine test that, like a pregnancy test, turns colors when it detects certain chemicals in drugs. The test is quick and inexpensive, but detects fewer than a dozen drugs, including opioids. The tests don’t detect drugs such as fentanyl and oxycodone, both of which have contributed to record overdoses across the country. Knowing what drugs a patients has taken can help doctors better decide a course of immediate treatment, as well as follow- up treatment such as rehabilitation, said doctors from the two emergency rooms and researchers from the Center for Substance Abuse Research at the University of Maryland, College Park. “We need to know the drug trends to know how to help people,” said Dr. Zachary D.W. Dezman, an attending physician in the emergency room at Midtown. Urine samples were tested from 106 patients at Prince George’s and 69 from the Midtown campus. Patients in Baltimore tested positive mostly for marijuana and fentanyl, a highly potent synthetic often added to heroin without users knowing.

The results highlight the complexities that exist in the current epidemic, said principal investigator Eric Wish, director of the Center for Substance Abuse Research. In some cases, dealers are mixing drugs without the knowledge of users. Many of the patients whose urine was tested misinformed doctors about what they had taken. “It used to be [drug users] didn’t want to admit what they were taking,” Wish said. “In this age they don’t know what they are taking.” Maryland’s drug-related deaths increase for seventh straight year, reach all-time high in 2017. “People are like walking drug stores now, there are so many drugs in their system,” Wish said. “A lot of the treatment now is focused on opioids. The important thing for the medical and treatment community to know is they are using far more than opioids.” Lawmakers and public health officials need to know the extent of fentanyl use to help reduce it, he said. “The emergency room is a place from which you can launch those public health efforts,” he said.

We are here to help with your recovery

www.mmbhs.com 410.766.6624

eedom FROM ADDICTION is possible ! BEGIN TODAY!

www.mmbhs.com • (410) 766-6624

RECOVERY ST S RT OA NY G BECAUSE IS POSSIBLE

By Morgan Eichensehr – Reporter, Baltimore Business Journal Jul 12, 2018, 7:00am CVS Health has installed safe medication disposal units in 19 of its pharmacies across Maryland, in an effort to help prevent opioid abuse and misuse.

w “This is for those medications that are sitting in your home that are no longer needed,” Davis said. “So maybe a patient had a broken leg and needed opioids for the pain, but has some pills left over — those drugs can be easily diverted for abuse by anyone who has access, and we want to help prevent that.” In addition to the medication disposal effort, the CVS Health Foundation is helping to fund opioid-related efforts at the local level, by awarding up to $2 million in grants to community health centers dedicated to supporting opioid addiction recovery. In Baltimore, a $85,000 grant is going to Total Health Care. The funding will be used to develop and implement care models to increase participation in Total Health Care’s substance abuse treatment program. Davis said taking part in combating the opioid crisis is in line with CVS’s mission as a health care company. “Our pharmacists are uniquely positioned as part of the local health care systems to play an important role in educating and also intervening on this issue,” Davis said. “Our mission is about helping people on their path to better health, and one of the ways we can do that is through heightened safety around prominent public health issues.” Maryland is among states across the U.S. that have been ravaged by the deadly ongoing opioid epidemic. Tom Davis, vice president of professional services for CVS Health (NYSE: CVS), said CVS is seeking to support communities that have been affected by the crisis with its medication disposal kiosks. The units will allow patients to drop off unused or excess pills from old prescriptions, so they can be handed over to police and safely disposed of.

CVS looks to prevent

prescription opioid misuse with disposal kiosks in Md.

Mental disorders are common

but treatments ARE AVAILABLE

mmbhs.com • (410) 766-6624

Over the course of two days in mid-August, more than 95 people in New Haven, Connecticut, overdosed.

Their drug, however, wasn’t heroin. It was synthetic cannabinoids, commonly sold as K2, Spice, or potpourri. The fallout from the incident was so widespread that experts have referred to it as a “mass casualty incident.” In nearby Baltimore, a new study by the University of Maryland’s Center for Substance Abuse Research (CESAR) published this month articulates many of the problems with identifying and treating synthetic cannabinoid overdoses.

Researchers studied urine samples of patients with suspected synthetic cannabinoid overdose at two different hospitals, the University of Maryland Medical Center Midtown Campus in Baltimore and the University of Maryland Prince George’s Hospital Center in Cheverly, a suburb of Washington, D.C.

They almost immediately hit a snag with their study.

If the patients had been using Spice, why wasn’t it showing up in their urine?

“When we got the results back, it was just kind of amazing because we expected to find a large percentage testing positive for the synthetic cannabinoids metabolites we were testing for, and what we found was that in the first go around only I think one specimen testing positive for it,” said principal investigator Eric Wish, PhD, a principal study investigator and director of CESAR at the University of Maryland, College Park, College of Behavioral & Social Sciences.

Despite testing the urine for 169 different drugs, including 26 metabolites of synthetic cannabinoids, it simply wasn’t there. The issue, say experts, highlights an urgent need for improved testing for so-called new psychoactive substances, including Spice and synthetic cathinones, also known as bath salts. These new drugs don’t show up on standard drug tests, making it difficult to form a clear diagnosis. Designer drugs continually manage to dodge legislation because whenever a certain variety is outlawed based on its chemical structure, a new similar chemical is manufactured and sold legally.>>>

“People want to know what they’ve been exposed to.”

“While the press and the media talk about Spice and K2 like it’s a single type of phenomenon, the truth can’t be further from that,” Wish told Healthline. “Basically what you have is some chemist in another country, oftentimes the DEA says it’s China, who waits and they see what has been put on the prohibited list by the government. And then they go ahead and they tweak the molecule a little so it’s no longer on the prohibited list and then they make it available.” New diagnostic measures One year later, researchers implemented an updated drug-test panel that increased the number of synthetic cannabinoids from 26 to 46. Even with this improved panel, only about one-quarter of the samples tested positive. The study also highlights several other findings that could potentially help improve immediate care for individuals overdosing on newer drugs at emergency departments as well as future public health initiatives. For instance, where a patient lives can foretell what drugs may be in their bloodstream. Researchers saw that in patients at Prince George’s County. Nearly half of them also tested positive for the hallucinogen PCP. Those at the Midtown Campus hospital were far more likely to have cocaine and fentanyl in their bloodstream. “The study provides public health officials, provides patients themselves, an understanding of the risks that they are exposed to,” said Dr. Zachary D.W. Dezman, an assistant professor of emergency medicine at the University of Maryland School of Medicine.

The fentanyl factor Fentanyl, a powerful synthetic opioid, is increasingly showing up across the United States with deadly results. In this study, researchers found that among all substances, fentanyl was the most likely to be found in combination with multiple other drugs. In some specimens, it was detected with as many as 12 others — indicating that users either aren’t aware what is in their drugs or that users of fentanyl are regularly using many different drugs simultaneously. “I’ve had a number of patients who once they were told they were fentanyl positive… started to seek treatment,” he added. Currently, fentanyl doesn’t show up on common “dip tests” used in hospitals, but Dezman hopes that will soon change. Synthetic cannabinoids, fentanyl, and synthetic cathinones represent a new challenge for members in the healthcare community to identify and treat, but by understanding which drugs are being used in which communities, better education and treatment options can be developed. “We can track people down to a particular area code, and that allows us to do things like create, potentially, a mobile van for education efforts to educate the neighborhood on the dangers they are being exposed to, signs to look out for an opioid overdose, distribute naloxone, and potentially also start a mobile opioid maintenance therapy van [to provide] methadone or Suboxone,” said Dezman. People “want to know what they’ve been exposed to,” said Dezman.

Ready to fight your addiction? We’ve got your back. No one fights alone. BAYSIDERECOVERYLLC.COM www.mmbhs.com | (410) 766-6624

Keep you r co i ns. I WANT CHAN G E www.mmbhs.com 410.766.6624